prostate-specific membrane antigen

You have access
Safety of PSMA-targeted molecular radioligand therapy with ¹⁷⁷Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312
Jeremie Calais, Johannes Czernin, Pan Thin, Jeannine Gartmann, Kathleen Nguyen, Wesley R. Armstrong, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, Magnus Dahlbom, Beile He, Rouzbeh Esfandiari, David Ranganathan, Ken Hermann, Matthias Eiber, Wolfgang P Fendler and Ebrahim Delpassand

Journal of Nuclear Medicine July 16, 2021, jnumed.121.262543; DOI: https://doi.org/10.2967/jnumed.121.262543
You have access
Positive Predictive Value and Correct Detection Rate of ¹⁸F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
Maythinee Chantadisai, Gabriel Buschner, Markus Krönke, Isabel Rauscher, Thomas Langbein, Stephan G. Nekolla, Kilian Schiller, Matthias M. Heck, Tobias Maurer, Alexander Wurzer, Hans-Juergen Wester, Calogero D’Alessandria, Wolfgang Weber and Matthias Eiber

Journal of Nuclear Medicine July 1, 2021, 62 (7) 968-974; DOI: https://doi.org/10.2967/jnumed.120.255661
You have access
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with ⁶⁷Cu
Lachlan E. McInnes, Carleen Cullinane, Peter D. Roselt, Susan Jackson, Benjamin J. Blyth, Ellen M. van Dam, Nicholas A. Zia, Matthew J. Harris, Rodney J. Hicks and Paul S. Donnelly

Journal of Nuclear Medicine June 1, 2021, 62 (6) 829-832; DOI: https://doi.org/10.2967/jnumed.120.251579
You have access
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with ¹⁷⁷Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort
Jeremie Calais, Andrei Gafita, Matthias Robert Eiber, Wesley Robert Armstrong, Jeannine Gartmann, Pan Thin, Kathleen Nguyen, Vincent Lok, Laura Gosa, Tristan Grogan, Rouzbeh Esfandiari, David Ranganathan, Martin S Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, Roger Slavik, Magnus Dahlbom, Ken Herrmann, Ebrahim S. Delpassand, Wolfgang Peter Fendler and Johannes Czernin

Journal of Nuclear Medicine May 20, 2021, jnumed.121.261982; DOI: https://doi.org/10.2967/jnumed.121.261982
You have access
A Place for Patent Protected and Unprotected Theranostic Approaches in Research and Clinic
Johannes Czernin

Journal of Nuclear Medicine May 20, 2021, jnumed.121.262566; DOI: https://doi.org/10.2967/jnumed.121.262566
You have access
PSMA-Targeted Therapeutics: A Tale About Law and Economics
Johannes Notni

Journal of Nuclear Medicine March 31, 2021, jnumed.121.262308; DOI: https://doi.org/10.2967/jnumed.121.262308
You have access
¹⁷⁷Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang and François Bénard

Journal of Nuclear Medicine April 1, 2021, 62 (4) 521-527; DOI: https://doi.org/10.2967/jnumed.120.250738
You have access
Head to head comparison of ⁶⁸Ga-NGUL and ⁶⁸Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study
Minseok Suh, Hyung-Jun Im, Hyun Gee Ryoo, Keon Wook Kang, Jae Min Jeong, Sneha Prakash, Sanjana S Ballal, Madhav P Yadav, Chandrasekhar Bal, Chang Wook Jeong, Cheol Kwak and Gi Jeong Cheon

Journal of Nuclear Medicine March 26, 2021, jnumed.120.258434; DOI: https://doi.org/10.2967/jnumed.120.258434
Open Access
Head-to-head comparison of ⁶⁸Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients
Melline GM Schilham, Patrik Zamecnik, Bastiaan M Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O Barentsz, James Nagarajah and Martin Gotthardt

Journal of Nuclear Medicine January 30, 2021, jnumed.120.258541; DOI: https://doi.org/10.2967/jnumed.120.258541
You have access
The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
Sara Harsini, Heather Saprunoff, Tina Alden, Behnoud Mohammadi, Don Wilson and François Bénard

Journal of Nuclear Medicine January 1, 2021, 62 (1) 81-87; DOI: https://doi.org/10.2967/jnumed.120.246983

Main menu

User menu

Search

prostate-specific membrane antigen

Pages